Determinants of medication adherence among older adults with type 2 diabetes using the health action process approach: A cross-sectional study
Determinanten der Medikamentenadhärenz bei älteren Erwachsenen mit Typ-2-Diabetes anhand des Health Action Process Approach: Querschnittsstudie
PLOS One · 25.09.2025 · 20 (9) · e0332235
DOI: 10.1371/journal.pone.0332235 ↗Auf einen Blick
Bei 179 älteren Erwachsenen mit Typ-2-Diabetes war die Medikamentenadhärenz häufig gering. Rauchen und wahrgenommene Barrieren waren mit mehr Nichtadhärenz verbunden; Recovery Self-Efficacy und Coping Planning mit weniger Nichtadhärenz.
Fragestellung
Welche Faktoren sind nach dem Health Action Process Approach mit der Medikamentenadhärenz bei älteren Erwachsenen mit Typ-2-Diabetes verbunden?
Methode
Deskriptive-analytische Querschnittsstudie bei 179 älteren Erwachsenen mit Typ-2-Diabetes; Erhebung mit MMAS-8 und HAPA-Fragebogen; Analyse mit Chi-Quadrat-Test und multipler binärer logistischer Regression.
Ergebnisse
62 % berichteten eine geringe Medikamentenadhärenz. Keine signifikanten Zusammenhänge mit soziodemografischen Faktoren. Rauchen: OR 4,309 (95 %-KI 1,18–15,67); wahrgenommene Barrieren: OR 1,036 (95 %-KI 1,01–1,06); Recovery Self-Efficacy: OR 0,924 (95 %-KI 0,86–0,99); Coping Planning: OR 0,963 (95 %-KI 0,93–0,99).
Schlussfolgerung der Autor:innen
Die Studie zeigt eine suboptimale Medikamentenadhärenz bei älteren Menschen. Rauchen und wahrgenommene Barrieren erhöhten die Wahrscheinlichkeit schlechter Adhärenz; höhere Recovery Self-Efficacy und Coping Planning wirkten protektiv.
Kernaussagen
- 62 % berichteten geringe Medikamentenadhärenz.
- Rauchen und wahrgenommene Barrieren erhöhten die Nichtadhärenz.
- Recovery Self-Efficacy und Coping Planning waren protektiv.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS One, online erschienen am 25.09.2025. Verfasst von Shiva Mohammadi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health care Management, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Medication Adherence. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus, Gerontologische Pflege
Abstract (Originalsprache)
Background and aims Medication adherence is a determinant of managing chronic disease. Failure to adhere to treatment can result in disease progression, increased hospitalizations, and a higher risk of complications and mortality. This study aimed to determine the level of medication adherence in older adults with type 2 diabetes based on the Health Action Process Approach (HAPA).
Methods
This study is a descriptive-analytical cross-sectional study that was conducted on 179 older adults with type 2 diabetes. Data were collected using the Morisky Medication Adherence Scale (MMAS-8-Item) and the HAPA questionnaire. We used the chi-square test to compare adherence to medication by demographic characteristics and multiple binary logistic regression analysis to predict factors related to medication adherence based on the HAPA dimensions.
Results
A total of 179 participants (87 men and 92 women) with a mean age of 64.65 ± 4.99 years were enrolled. Low medication adherence was reported by 62% of participants. No significant associations were found between socio-demographic factors (gender, marital status, education, employment, and income) and adherence levels. Logistic regression analysis revealed that smoking (OR = 4.309, 95% CI [1.18, 15.67], p = 0.027) and perceived barriers to adherence (OR = 1.036, 95% CI [1.01, 1.06], p = 0.001) were significantly associated with increased odds of medication non-adherence. Conversely, higher recovery self-efficacy (OR = 0.924, 95% CI: 0.86–0.99, p = 0.027) and coping planning (OR = 0.963, 95% CI: 0.93–0.99, p = 0.022) were associated with reduced odds of non-adherence. The most common self-reported reasons for suboptimal adherence were lack of affordability (17.5%), lack of family support (10%), and poor understanding of the disease (9.4%).
Conclusion
This study highlights that older people had suboptimal adherence to medication. Smoking and perceived barriers were significant risk factors, increasing the likelihood of poor adherence. Conversely, higher levels of recovery self-efficacy and coping planning served as protective factors, reducing the risk of non-adherence. Policymakers and planners should consider the mentioned factors in designing interventions to change behavior for chronic diseases like diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health care Management, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
ORCID-Profile: Zhila Najafpour
Zitieren
APA
Mohammadi, S., Khorami, B., Seyedtabib, M., & Najafpour, Z. (2025). Determinants of medication adherence among older adults with type 2 diabetes using the health action process approach: A cross-sectional study. PLOS One, 20(9), e0332235. https://doi.org/10.1371/journal.pone.0332235
Vancouver
Mohammadi S, Khorami B, Seyedtabib M, Najafpour Z. Determinants of medication adherence among older adults with type 2 diabetes using the health action process approach: A cross-sectional study. PLOS One. 2025;20(9):e0332235. doi:10.1371/journal.pone.0332235
BibTeX
@article{Mohammadi2025,
author = {Mohammadi, Shiva and Khorami, Bahareh and Seyedtabib, Maryam and Najafpour, Zhila},
title = {Determinants of medication adherence among older adults with type 2 diabetes using the health action process approach: A cross-sectional study},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {9},
pages = {e0332235},
doi = {10.1371/journal.pone.0332235}
}
EUVIMED